ArticleJournal of autoimmunity2022

SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis.

Cumali Efe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.